Rideshare Intervention Improves Colonoscopy Completion in Colorectal Cancer Screening

Researchers have found that providing rideshare services to patients with abnormal fecal immunochemical test (FIT) results can significantly improve colonoscopy completion rates, leading to a reduction in colorectal cancer (CRC) cases and deaths. A microsimulation model was used to determine the outcomes and cost-effectiveness of a rideshare intervention in a population-based CRC screening program. The study found that increasing colonoscopy completion from 35% to 70% resulted in a reduction of CRC cases per 1000 by 26.3%, CRC deaths per 1000 by 32.5%, and 24.9 life-years gained per 1000.

Key Takeaways:

  • The study used the CRC-Simulated Population Model for Incidence and Natural History microsimulation model to simulate the outcomes and cost-effectiveness of a rideshare intervention in a population-based CRC screening program.
  • Four single-age cohorts (ages 45, 55, 65, and 70 years) of 10 million people each were simulated, with similar sex distribution as the US population.
  • Using a rideshare intervention starting at age 45 years that costs $100 per ride to increase colonoscopy completion from 35% to 70% was associated with a reduction in CRC cases per 1000 by 26.3% (30.7 vs 41.6 cases per 1000) and CRC deaths per 1000 by 32.5% (9.8 vs 14.6 cases per 1000).
  • The cost-effectiveness of the rideshare intervention was $43 308 per 1000 people screened and saved $330 587 per 1000 people screened.
  • The study concluded that a rideshare intervention to improve colonoscopy completion in a population with abnormal FIT results is cost saving up to $100 per ride.

Statistics:

  • Reduces CRC cases per 1000 by 26.3% (30.7 vs 41.6 cases per 1000)
  • Reduces CRC deaths per 1000 by 32.5% (9.8 vs 14.6 cases per 1000)
  • Increases life-years gained per 1000 by 24.9
  • Cost-effectiveness of the rideshare intervention is $43 308 per 1000 people screened and saves $330 587 per 1000 people screened
  • The rideshare intervention is cost saving up to $100 per ride

Sources:

  • Modeled Cost-Effectiveness of a Rideshare Program to Facilitate Colonoscopy Completion. JAMA Network Open, 2025;8(9).
  • Amer Medical Assoc, 330 N Wabash Ave, Ste 39300, Chicago, IL 60611-5885, USA.
  • Laura Matrajt, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rachel B. Issaka, Pedro Nascimento de Lima, and Carolyn M. Rutter, authors of the study.